TNFRSF18 Antikörper
Kurzübersicht für TNFRSF18 Antikörper (ABIN610419)
Target
Alle TNFRSF18 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human GITR in EIA and on cell surface in FACS. Preincubation of the receptor with an excess of this mAb will block binding of recombinant GITR Ligand.
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Recombinant human GITR, PHA stimulated human PBL.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG3 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, Flo
Usage: The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 50 mM sodium phosphate, pH 7.5, 500 mM potassium chloride, 150 mM sodium chloride
-
Konservierungsmittel
- Azide free
-
Handhabung
- Do not freeze. Open under aseptic conditions.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze. Open under aseptic conditions.
-
-
-
: "Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells." in: The Journal of biological chemistry, Vol. 276, Issue 35, pp. 32663-9, (2001) (PubMed).
-
-
- TNFRSF18 (Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18))
-
Andere Bezeichnung
- TNFRSF18 / GITR
-
Hintergrund
-
Name/Gene ID: TNFRSF18
Family: TNF Receptor
Synonyms: TNFRSF18, AITR, CD357, CD357 antigen, GITR, GITR-D -
Gen-ID
- 8784
-
UniProt
- Q9Y5U5
-
Pathways
- Cancer Immune Checkpoints
Target
-